In contrast, APOBEC3A and APOBEC3B do not potently block HIV infection of T cells [5–7, 9], which are the primary target of HIV (although a target-cell effect has been reported in monocytes for APOBEC3A) [10]. Here, APOBEC3A is linked to HIV infectious disease.